In comparative systematic reviews of diagnostic accuracy, inconsistencies between direct and indirect comparisons may lead to bias. We investigated whether using individual patient data (IPD) can adjust for this form of bias.
Introduction
Studies of test accuracy evaluate how well a test is able to identify patients with the target condition, or target event, by comparing test results against the reference standard. Systematic reviews of test accuracy studies try to obtain more precise summary estimates of the accuracy and to explore sources of variability in accuracy. Some reviews target not just one medical test but two or more, and evaluate whether the accuracy of one test is better than that of another one. In such comparative systematic reviews one can include direct and indirect test comparisons. Direct comparisons, also known as head-to-head comparisons, evaluate two or more tests in the same study, preferably in the same patients. Indirect comparisons refer to data from separate studies: one test is evaluated in a series of studies, while the second test is evaluated in different studies and different patients.
For various reasons, e.g. different test settings, different patients, indirect comparisons are more prone to bias than direct comparisons, and one may be tempted to restrict comparative reviews to direct comparisons [1] . On the other hand, excluding indirect comparisons in systematic reviews may lead to a loss in precision in the summary estimates, and fewer data to explore heterogeneity.
Inconsistency in the treatment effects between direct and indirect comparisons has previously been observed in systematic reviews of competing interventions [66] .
This finding also applies to systematic reviews of diagnostic test accuracy. Takwoingi et al. compared results from direct and indirect comparisons of diagnostic tests in 36 reviews and found that indirect comparisons do give different results than direct comparisons and the direction of the bias cannot be predicted [2] .
Ways to correct for indirectness were investigated by several researchers. Leeflang et al. analyzed 17 comparisons between assays for D-Dimer testing and found a significant effect of indirectness in 5 of them. In order to make results from indirect comparisons in correspondence with results from direct comparisons, they used a bivariate random effects meta-regression model with assay-type and directness as covariates and included study features to correct for the effect of indirectness on sensitivity or specificity. Leeflang's results showed that adjusting for study features did not have much effect on removing the indirectness [67] . So it is still doubtful whether and how direct and indirect comparisons in systematic reviews and meta-analysis of test accuracy studies can be combined successfully, i.e. without introducing bias.
All previous studies were based on aggregated data at study level, which vary with the threshold for test positivity, the clinical reference standard, and the target population. This information can often be obtained from primary studies. An advanced approach to summarizing the evidence from primary studies is to acquire the original data from included studies and to perform statistical analyses at the individual patient data (IPD) level. IPD meta-analysis offers the possibility of performing additional types of analyses, such as reconciling thresholds and reference standards from primary studies to the same value, adjusting for baseline differences in study-level as well as patient-level characteristics, and using continuous results instead of dichotomized cut-off values [68] .
The objective of this case study is to investigate whether using IPD from primary studies can overcome the limitations in analyses based on study level data. We explored how we can adjust for indirectness with IPD meta-analysis, and developed and evaluated methods for adjusting the indirect comparisons, so that the results from such comparisons are more consistent with those from direct comparisons.
Data

Data Acquisition
This IPD case study was facilitated by the EXPORT dataset used in the "Excessive Response Prediction using Ovarian Reserve Tests" project, a collaborative IPD metaanalysis comparing the accuracy of Anti-Müllerian Hormone (AMH), Antral Follicle Count (AFC) and Follicle Stimulation Hormone (FSH) in predicting poor ovarian response in in vitro fertilization (IVF) [69] . The dataset contained 34 databases including 6,852 women undergoing IVF.
These ovarian reserve tests (ORT) were initially suggested to have a good predictive value for pregnancy, but recent studies showed that these tests are more effective in predicting the ovarian response [70] . AMH, AFC and FSH are three most widely used ORTs frequently used prior to IVF treatment to predict poor response to ovarian stimulation [71] .
Patient characteristics, such as age, BMI or duration of subfertility, not only have a strong predictive power for ovarian response but also influence the inherent discriminatory accuracy of the ORTs [69]. These variables can help in finding out whether the difference in baseline characteristics is the source of bias in indirect comparisons and provide us the probability to adjust for indirectness by including covariates.
Comparisons were limited to pairs of tests which are the simplest and most common cases of test comparison. So from the dataset, we can generate 3 pairwise comparisons between two tests: AMH vs FSH, AMH vs AFC, FSH vs AFC, which could make best use of the IPD dataset and provide more evidence to evaluate the usefulness of the adjustments. In each pairwise comparison, a direct comparison was defined as a study in which patients had taken both tests; an indirect comparison was defined as one in which patients had undergone only one of the two tests. Many test results are continuous in nature, but classified as positive and negative, thus in most of the diagnostic test accuracy studies, data are generally reported in a dichotomous way, i.e. in 2 by 2 tables. This common and simple way of reporting provides reduced information for meta-analyses, and neglects the potential diagnostic information contained in continuous test results. Different formats of reporting in primary studies will lead to different statistical methods implemented in data analysis.
Dichotomous Tests and Continuous Tests
So the three ORTs are treated as both dichotomous tests and continuous tests which will be discussed separately in following sections.
Methods
There are two main sources of bias in indirect comparisons: heterogeneity between studies, which may be from different reference standards or thresholds in primary studies, and differences in baseline characteristics, which may lead to confounding and effect modification. We propose two corresponding types of adjustments with IPD. One focuses on the comparability of test results from different studies (Type I), the second on covariate effect (Type II). The two adjustments are on different layers: only test results (index tests, reference standard, or both) are needed for Type I adjustment, which are the essential information from the primary studies; more information, e.g. patient characteristics, are needed for Type II adjustment.
These two types of adjustments could be performed individually or together. When there are no sufficient patient level data containing patient characteristics, thus Type II adjustment is not feasible, we can use only Type I adjustment, and vice versa. But it is highly recommended to perform Type I adjustment all the time as the first step when it is possible, since adjustment on test results can influence the estimate of test accuracy directly. So in the analyses of this case study, Type I adjustment was implemented in Analysis 1 and Type I + Type II adjustments were implemented in Analysis 2.
Type I Adjustment: Adjustment of Reference Standard and Test Results
In meta-analysis of DTA studies, the included primary studies may use different reference standards or use the same reference standard but with different cut-off values to define diseased and non-diseased patients. This difference may lead to heterogeneity in test accuracy. IPD provides the opportunity to redefine the disease status of all patients if individual level information about the reference standard was reported in the dataset. So by adjusting reference standard, we can make sure that test accuracies in different primary studies are measured against the same reference standard and same cut-off point.
Besides the reference standard, the definition of the positivity of index tests may also vary among studies and the differences in sensitivity and specificity between studies may result from the use of different threshold levels [73] . To make the pooling of data from primary studies more comparable, for each index test a single cut-off value should be defined and applied to all the patients in all studies. The general cut-off point of index test can be obtained by maximizing overall accuracy or minimizing the total cost of misclassification, and this value should be reasonable and in the range of cut-offs reported in the primary studies. We first consider dichotomous tests. In systematic reviews of dichotomous tests, meta-analysis of sensitivity and specificity values is preferred over meta-analysis of likelihood ratios [77], so we compare dichotomous tests by their sensitivities and specificities. Pooling of sensitivity and specificity separately is not recommended since the paired nature of sensitivities and specificities from individual studies is ignored. A robust and commonly used approach is the construction of an SROC curve, which considers the underlying relationship between sensitivity and specificity.
However, in this IPD meta-analysis, we combined data but not estimates from individual studies, and sensitivity and specificity were defined on a per-observation basis, so they can be analyzed separately. In this study, we have patient characteristics such as age, BMI level and duration of subfertility as covariates for Type II adjustment. The parameter estimation was implemented with generalized estimating equations (GEE) with exchangeable correlation structure. By comparing parameters from a model including these covariates with parameters of the basic model without covariates, we can investigate whether covariate adjustment is a way to correct for indirectness.
For continuous tests, AUC was used as a measure of test accuracy. Janes and Pepe showed that when confounding was present the overall ROC curve and AUC substantially differed from stratum specific ROC curve and AUC [74] . Thus, they suggested that methods for covariate adjustment are needed in ROC analysis. In this study, adjusting for covariate effect is implemented with covariate-adjusted ROC (AROC) curve [78, 79] . With this model, covariates that may influence the test accuracy could be statistically adjusted in the ROC analysis.
Comparing Diagnostic Test Accuracy in Direct and Indirect Comparisons
For dichotomous tests, we include binary variable Z that indicates indirectness in comparison and the interaction term with testtype, then the hypothesis H 0 : β 3 D = 0 (H 0 : β 3 D = 0), where is the parameter of the interaction term in formula 4.1 (or formula 4.2) (see Appendix 1), is equivalent to a statement that there is no difference between direct and indirect comparisons of test sensitivity (1-specificity).
For continuous tests, in each pair of comparisons, AUCs of each test were estimated with empirical (non-parametric) method in direct comparison and indirect comparison separately, and compared with DeLong's test for two correlated ROC curves in paired data (direct comparisons) and its extension for unpaired ROC curves in indirect comparisons [80] . In Type II adjustments, AROC was used as the measure of accuracy instead of AUC. Then we can see if there are inconsistencies between comparative results from direct and indirect comparisons.
Results
Dataset
The final dataset only included women that provided information about ovarian response, in terms of number of oocytes, who had taken at least one of the three ORTs. As a result, 4,762 women from 32 databases were suitable for the analysis of tests comparison, in which 1,001 (21.0%) women had a poor response. 
Reference Standard
Different cut-off points were used in primary studies to define 'poor response'.
Since in our IPD dataset every study reported the exact number of oocytes for each individual patient, we defined poor response for all individual patients according to a single and commonly used definition: the yield of 4 or less oocytes at follicle [81].
Dichotomous Tests
In this study, we defined the single cut-off value for each ORT in all studies by maximizing the Youden's index [82] (Sensitivity + Specificity -1) based on the dataset as well as consulting with recently published systematic reviews of each ORT [83] [84] [85] . We know that using Youden's index is debatable, but this way we 116 have an objective and uniform method for selecting a cutoff. AMH test results less than 1.28 ng/ml were defined as positive; AFC number less than or equal to 8 were defined as positive; FSH test results larger than or equal to 7.72 IU/L were defined as positive. These values are all in the range of cut-offs reported in the systematic reviews of these ORTs [83] [84] [85] . Type I adjustment only, we cannot always remove the bias of indirectness.
We further adjusted the models by including the following covariates in the regression models for sensitivity (1-specificity): age and accordingly the interaction term of age and test type (Analysis 2). After Type II adjustment, the parameter β 3 which indicates the differences in sensitivities or specificities is still significant. The results we got from Analysis 2 showed that the inclusion of patient characteristic had no influence on those comparisons, and with Type II adjustment we cannot remove the bias of indirectness either. 
Continuous Tests
The ROC curves and AUCs after adjusting for reference standard and standardizing the test results (Type I adjustments) are shown in Figure 4 .1 and Table 4 .3. In the first pair, both direct comparisons and indirect comparisons gave the same conclusion:
AMH had a better performance than FSH, but the discriminatory power of both tests in direct comparisons were higher than in indirect comparisons. In the second pair, the difference in AUCs between AFC and FSH (0.0948, p<0.01) is significant in direct comparisons but not significant (0.0678, p=0.09) in indirect comparisons. It was observed that AFC performed much better when directly compared to FSH. In the third pair, the difference between AFC and AMH is significant (-0.0830, p<0.01) in indirect comparison but not significant (-0.0176, p=0.29) in direct comparison. This is due to the increase from 0.78 to 0.83 in the AUC of AMH and the drop from 0.76 to 0.75 in the AUC of AFC in the indirect comparison. The inconsistencies were observed after Type I adjustments. 
Discussion
In this IPD case study, we proposed two types of adjustments to correct for the effect of indirectness in comparative systematic reviews of diagnostic test accuracy studies. Type I adjustments were focused on threshold effect and reference standard issues, while Type II adjustments additionally focused on patient characteristics.
These adjustments were not successful in removing the bias from indirectness in the present case study: differences between direct and indirect comparisons persisted, even after applying these adjustments. lead to the decision of AMH being the test to rely on. The same can be seen in the comparison between FSH and AFC, but this time the other way around. Although the difference is not statistically significant, the results from the direct comparison (both tests similar accuracy) may lead to a different decision than the results from the indirect comparisons (AFC higher sensitivity than FSH). Thus, to get a more reliable comparison result and better evidence to support the decision, a comparative study design in diagnostic test accuracy studies is needed. Systematic reviews will also benefit from better design of primary studies. Comparative studies should be encouraged in DTA studies.
Conclusion
Comparative results of test accuracy obtained through indirect comparisons are not always consistent with those obtained through direct comparisons. Study level covariates were considered for adjusting the bias of indirectness, but the adjustment did not successfully solve the problem. Systematic reviews with IPD are considered as the gold standard, but even with IPD, Type I and Type II adjustments still cannot remove the bias of indirectness successfully. There is no generally applicable way to make results of indirect comparisons more comparable to results of direct comparisons. So we caution that evidence from indirect comparisons should not be combined with direct comparisons, if sufficient direct comparisons are available. It is also an implication for researches working on primary studies of diagnostic test accuracy: even diagnostic test can be evaluated without a competitor, but it is still valuable to perform a comparative study so that systematic reviewers can benefit from that.
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